ADRIAMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL (AVCF) COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN PREMENOPAUSAL BREAST-CARCINOMA - PERSONAL RESULTS

被引：0
|
作者：
MATHE, G [1 ]
MISSET, JL [1 ]
PLAGNE, R [1 ]
REIZENSTEIN, P [1 ]
BELPOMME, D [1 ]
LEMEVEL, B [1 ]
GUERRIN, J [1 ]
FUMOLEAU, P [1 ]
METZ, R [1 ]
DELGADO, M [1 ]
DEVASSAL, F [1 ]
ERIGUCHI, M [1 ]
SCHNEIDER, M [1 ]
机构：
[1] PAUL BROUSSE HOSP,DEPT HAEMATOL & ONCOL,VILLEJUIF,FRANCE
来源：
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 1986年 / 12卷 / 1-3期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：143 / 145
页数：3
相关论文
共 50 条
  • [31] 5-FLUOROURACIL, CYCLOPHOSPHAMIDE, AND VINCRISTINE FOR ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
    TRIOZZI, PL
    BRANTLEY, A
    FISHER, S
    COLE, TB
    CROCKER, I
    HUANG, AT
    CANCER, 1987, 59 (05) : 887 - 890
  • [32] COMBINATION CHEMOTHERAPY USING CYCLOPHOSPHAMIDE VINCRISTINE METHOTREXATE AND 5-FLUOROURACIL IN SOLID TUMORS
    COSTANZI, JJ
    COLTMAN, CA
    CANCER, 1969, 23 (03) : 589 - &
  • [33] ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL IN TREATMENT OF METASTASIZING BREAST-CANCER
    HOFFKEN, K
    SEEBER, S
    BOECKER, WR
    SCHMIDT, CG
    ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1976, 86 (02): : 135 - 145
  • [34] CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer - Results by demographic and clinical subgroups
    Ron, IG
    Wigler, N
    Borovik, R
    Peretz, T
    Rizel, S
    Shani, A
    Brenner, J
    Farbstein, H
    Brenner, HJ
    Chaitchik, S
    Catane, R
    Inbar, MJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 520 - 522
  • [35] CHEMOTHERAPY OF ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL OF VINCRISTINE, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE (VAC) VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, AND PREDNISONE (CMFP)
    CARMOPEREIRA, J
    COSTA, FO
    HENRIQUES, E
    CANCER, 1981, 48 (07) : 1517 - 1521
  • [36] Doxorubicin and Cyclophosphamide versus Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Adjuvant Chemotherapy in Breast Cancer
    Livi, L.
    Saieva, C.
    Borghesi, S.
    Cardillo, C. De Luca
    Scotti, V.
    Mangoni, M.
    Greto, D.
    Cataliotti, L.
    Paiar, F.
    Bianchi, S.
    Biti, G. P.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (05) : 558 - 565
  • [37] Effects of Metformin on the Survival Rate of CMF (Cyclophosphamide, Methotrexate and 5-fluorouracil)-treated Rats
    Alhowail, Ahmad
    Aldubayan, Maha
    Alqasomi, Abdulmajeed
    Alharbi, Ibrahim
    Alharbi, Hindi
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2020, 16 (03) : 201 - 204
  • [38] A RANDOMIZED MULTICENTER TRIAL OF CYCLOPHOSPHAMIDE, NOVANTRONE AND 5-FLUOROURACIL (CNF) VERSUS CYCLOPHOSPHAMIDE, ADRIAMYCIN AND 5-FLUOROURACIL (CAF) IN PATIENTS WITH METASTATIC BREAST-CANCER
    BENNETT, JM
    BYRNE, P
    DESAI, A
    WHITE, C
    DECONTI, R
    VOGEL, C
    KREMENTZ, E
    MUGGIA, F
    DOROSHOW, J
    PLOTKIN, D
    GOLOMB, H
    MUSS, H
    BRODOVSKY, H
    GAMS, R
    HORGAN, LR
    BRYANT, S
    WEISS, A
    CARTWRIGHT, K
    DUKART, G
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 179 - 185
  • [39] Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma
    Hainsworth, JD
    Jolivet, J
    Birch, R
    Hopkins, LG
    Greco, FA
    CANCER, 1997, 79 (04) : 740 - 748
  • [40] ESTROGEN-RECEPTORS AND RESPONSE TO CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN ADVANCED BREAST-CANCER
    CHANG, JC
    HILL, GW
    WERGORSKI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 411 - 411
12345